Pelthos Therapeutics Inc. logo

Pelthos Therapeutics Inc. (PTHS)

Market Closed
17 Jul, 20:00
AMEX AMEX
$
26. 99
+0.28
+1.0483%
$
17.22M Market Cap
- P/E Ratio
- Div Yield
9,900 Volume
- Eps
$ 26.71
Previous Close
Investors:
Add Transaction
Day Range
26.5 28.37
Year Range
16.5 37.5
Want to track PTHS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Pelthos Therapeutics Inc. (PTHS) Statistics

Valuation metrics

Market Cap 17.22M
Enterprise value 38.1M
Trailing P/E (ttm) -0.66
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 0.63
Price/Book (mrq) 2.53
Enterprise Value/Revenue 1.38
Enterprise Value/EBITDA -0.76

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 9.71K
Average volume (90 days) 23.86K

Price summary

52-Week low 16.5
52-Week high 37.5
Beta -
50-Day moving average 26.99
200-Day moving average 24.13

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 2 Jul 2025

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -1.86%
Operating margin -1.58%

Operational effectiveness

Return on assets -0.35%
Return on equity -1.64%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) 8.36
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -15.58
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 9.73
Total debt (mrq) -
Total Debt/Equity (mrq) 1.51
Current ratio (mrq) 2.76%
Book value per share (mrq) 10.6

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -